Furosemide and Taltz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Taltz (ixekizumab). Common drug interactions include rash among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Taltz. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,777 Taltz users. Check the latest studies of Taltz.

On Jul, 06, 2026

78 people who take Furosemide and Taltz together, and have interactions are studied.

What are the common drug interactions of Furosemide and Taltz, by gender? *:

female:

Rash
Pain
Psoriasis (immune-mediated disease that affects the skin)
Pneumonia
Amylase increased
Burning sensation
Drug ineffective
Injection site swelling
Lipase increased
Lung infection

male:

Cardiac failure congestive
Ejection fraction decreased (systolic heart failure)
Lung neoplasm malignant (cancer tumour of lung)
Oesophageal carcinoma (cancer tumour of oesophagus)
Diarrhoea
Herpes zoster
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Proteinuria (presence of protein in the urine)
Rebound effect (take-back effect)
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

What are the common drug interactions of Furosemide and Taltz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Discomfort
Drug ineffective
Pain
Rash

40-49:

Diarrhoea
Herpes zoster
Proteinuria (presence of protein in the urine)
Rebound effect (take-back effect)
Renal impairment (severely reduced kidney function)
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Dyspnoea (difficult or laboured respiration)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic failure (liver failure)

50-59:

Anaemia of chronic disease
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Gastric haemorrhage (bleeding stomach)
Syncope (loss of consciousness with an inability to maintain postural tone)
Amylase increased
Chronic respiratory failure
Diarrhoea
Dyskinesia (abnormality or impairment of voluntary movement)
Gait disturbance
Hypoxia (low oxygen in tissues)

60+:

Hepatocellular carcinoma (liver cancer)
Pneumonia
Rash
Pyrexia (fever)
Acute respiratory distress syndrome
Anaemia (lack of blood)
Blood creatinine increased
Dementia (madness)
Dyspnoea (difficult or laboured respiration)
Respiratory tract inflammation

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 39 people, 50.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 19 people, 24.36%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 6 people, 7.69%
Oedema (fluid collection in tissue): 5 people, 6.41%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.13%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 5.13%
Asthma: 4 people, 5.13%
Arthropathy: 4 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Taltz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously